Product Description: Carteolol hydrochloride (OPC-1085 hydrochloride) is a non-selective beta blocker used to treat glaucoma.
Applications: COVID-19-immunoregulation
Formula: C16H25ClN2O3
Citations: J Pharmaceut Biomed. 2020, 113870./ACS Omega. 2022 Aug 8;7(32):27950-27958.
References: [1]Kuwahara, K., et al., Carteolol hydrochloride protects human corneal epithelial cells from UVB-induced damage in vitro. Cornea, 2005. 24(2): p. 213-20./[2]Trinquand, C., et al., [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. J Fr Ophtalmol, 2003. 26(2): p. 131-6.
CAS Number: 51781-21-6
Molecular Weight: 328.8343
Compound Purity: 99.96
Research Area: Cardiovascular Disease; Endocrinology
Solubility: DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)/H2O : ≥ 25 mg/mL
Target: Adrenergic Receptor